ISALA
πΏπ¦South Africa
Clinical Trials
38
Active:3
Completed:20
Trial Phases
5 Phases
Phase 1:1
Phase 2:1
Phase 3:2
+2 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (28 trials with phase data)β’ Click on a phase to view related trials
Not Applicable
20 (71.4%)Phase 4
4 (14.3%)Phase 3
2 (7.1%)Phase 1
1 (3.6%)Phase 2
1 (3.6%)Early Mindfulness Based Cognitive Therapy for Prevention of Psychological Distress in Cancer Patients
Not Applicable
Not yet recruiting
- Conditions
- Mindfulness Based Cognitive TherapyCancer
- First Posted Date
- 2025-08-15
- Last Posted Date
- 2025-08-15
- Lead Sponsor
- Isala
- Target Recruit Count
- 208
- Registration Number
- NCT07124481
Effect of Post-operative Chlorhexidine on Postoperative Pain and Complications After Surgical Removal of Mandibular Third Molars
Not Applicable
Completed
- Conditions
- Third Molars Extraction
- First Posted Date
- 2025-03-18
- Last Posted Date
- 2025-03-18
- Lead Sponsor
- Isala
- Target Recruit Count
- 145
- Registration Number
- NCT06880952
- Locations
- π³π±
Isala Hospital, Zwolle, Overijssel, Netherlands
Direct Superior Approach Versus PosteroLateral Approach in Total Hip Arthroplasty (SPLAsH)
Not Applicable
Recruiting
- Conditions
- Osteoarthritis, Hip
- First Posted Date
- 2024-04-02
- Last Posted Date
- 2025-08-03
- Lead Sponsor
- Isala
- Target Recruit Count
- 211
- Registration Number
- NCT06342843
- Locations
- π³π±
Amphia, Breda, Brabant, Netherlands
π³π±Medisch Centrum Leeuwarden, Leeuwarden, Friesland, Netherlands
π³π±Isala, Zwolle, Overijssel, Netherlands
Evaluating the Safety of Shortened Infusion Times for dIfferent Oncological Immunotherapie
Phase 4
Recruiting
- Conditions
- OncologyInfusion Reaction
- Interventions
- First Posted Date
- 2023-09-11
- Last Posted Date
- 2025-05-21
- Lead Sponsor
- Isala
- Target Recruit Count
- 679
- Registration Number
- NCT06031233
- Locations
- π³π±
Isala Hospital, Zwolle, Netherlands
Telemonitoring Among Patients With Multiple Myeloma
Not Applicable
Recruiting
- Conditions
- Multiple Myeloma
- First Posted Date
- 2023-07-27
- Last Posted Date
- 2023-07-27
- Lead Sponsor
- Isala
- Target Recruit Count
- 150
- Registration Number
- NCT05964270
- Locations
- π³π±
Isala Klinieken, Zwolle, Overijssel, Netherlands
- Prev
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- Next
News
No news found